• TMEM16F in Kupffer Cells Protects Against Listeria-Induced I

  2026-06-10

  This study reveals that TMEM16F expression in liver Kupffer cells is essential for defending against Listeria monocytogenes infection by preserving plasma membrane integrity and regulating inflammation. The findings clarify the cell-type-specific mechanisms underlying host protection and offer new directions for dissecting inflammatory responses in infectious disease models.

• 5-HT3 Antagonists Inhibit Renal OCT2/MATE1: Mechanistic Insi

  2026-06-09

  This study systematically characterizes the in vitro inhibition of renal organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1) by a panel of 5-HT3 receptor antagonist antiemetic drugs, including tropisetron. The findings clarify drug-transporter interactions relevant to neuroscience receptor modulation and pharmacokinetic research, informing both experimental design and awareness of potential drug-drug interactions.

• Idoxuridine: Applied Protocols and Troubleshooting in Antivi

  2026-06-09

  Idoxuridine (5-iodo-2'-deoxyuridine) is a cornerstone antiviral research tool for dissecting viral DNA replication and optimizing herpes simplex virus models. This guide distills actionable workflows, advanced troubleshooting, and cross-domain insights, informed by cutting-edge studies and rigorous product validation.

• Spatial Transcriptomics Uncovers Cortical Neuron Vulnerabili

  2026-06-08

  This study applies spatial transcriptomics to identify which cortical neurons are most susceptible to Lewy pathology in Parkinson's disease, revealing a conserved molecular dysfunction signature. The findings enhance our understanding of PD progression and open new avenues for targeted research on neuronal vulnerability and neurodegeneration.

• Optimizing Organoid Assays with DAPT (GSI-IX): Protocols & P

  2026-06-08

  DAPT (GSI-IX) unlocks precision control of Notch signaling for organoid, neurodegeneration, and cancer research. This guide details practical workflows, troubleshooting strategies, and translational insights based on recent breakthroughs in organoid modeling and disease pathway interrogation.

• Nigericin Sodium Salt: Technical Guidance for Ion Transport

  2026-06-07

  Nigericin sodium salt is a potassium ionophore used to manipulate ion gradients and cytoplasmic pH in cell-based and biochemical workflows. It is not intended for diagnostic or medical applications and requires careful attention to solubility and storage parameters to maintain reproducibility.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic

  2026-06-06

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive, specific detection of rabbit primary antibodies in fluorescence-based immunoassays. It is not recommended for use with non-rabbit primaries or outside validated immunofluorescence, flow cytometry, and microscopy workflows.

• Cell Surface GlycoRNA–RBP Nanoclusters Mediate Peptide Entry

  2026-06-05

  The referenced study uncovers that RNA binding proteins (RBPs) and glycoRNAs co-organize into nanoclusters on the cell surface, facilitating the entry of cell penetrating peptides like TAT. This finding redefines our understanding of the cell surface proteome and highlights new avenues for investigating membrane-associated RNA–protein complexes, with implications for targeted delivery and interactome mapping.

• Tobramycin in Translational Microbiology: Mechanisms and Str

  2026-06-05

  This thought-leadership article explores Tobramycin as both a mechanistic probe and strategic asset for translational researchers targeting Gram-negative bacterial infections. By integrating evidence from foundational studies and current protocol advances, we outline how Tobramycin's molecular action, comparative efficacy, and workflow versatility empower robust antibiotic resistance research. We also highlight APExBIO's offering and chart a visionary roadmap for next-generation microbiology applications.

• Cortistatin Mitigates Glucocorticoid-Induced Femoral Head Os

  2026-06-04

  This study demonstrates that cortistatin (CST) prevents glucocorticoid-associated osteonecrosis of the femoral head by antagonizing apoptosis and metabolic disruption in osteoblasts through the GHSR1a/Akt signaling pathway. The findings highlight the translational potential of targeting Akt-mediated processes in bone disease models and inform the design of future mechanistic and therapeutic studies.

• Clozapine: Mechanisms, Protocols, and Evidence in Schizophre

  2026-06-04

  Clozapine is an atypical antipsychotic medication with unique receptor affinities and ERK1/2 signaling effects, making it a critical tool in schizophrenia research. Its distinct mechanism and protocol reliability support advanced investigations into treatment-resistant models and neurotoxicity. This article synthesizes peer-reviewed data and validated protocols for optimized laboratory use.

• Cysteine-191 Targeting Blocks Gasdermin D Activation in Pyro

  2026-06-03

  This study identifies NU6300 as a covalent inhibitor of gasdermin D, blocking its cleavage and palmitoylation at cysteine-191. The findings reveal a mechanistic advance in controlling pyroptotic cell death, with implications for inflammatory disease research and therapeutic strategy development.

• Technical Guidance for Using AZD8055 as an mTOR Inhibitor

  2026-06-03

  AZD8055 is a potent, selective mTOR kinase inhibitor that enables researchers to study dual mTORC1/mTORC2 signaling in cellular and animal models. It is best applied in mechanistic studies of cancer cell proliferation and metabolism, but should not be used where clinical efficacy endpoints are the primary objective due to limited late-phase translational success.

• Indomethacin: Advanced Mechanistic Insights for Inflammation

  2026-06-02

  Unlock the multifaceted potential of Indomethacin, a nonsteroidal anti-inflammatory drug, in cutting-edge inflammation research. Discover how its unique mechanisms extend beyond COX inhibition to impact lipid metabolism and membrane signaling, providing new avenues for experimental design.

• CFTRinh-172: Advancing Precision in CFTR Inhibitor Research

  2026-06-02

  Explore the unique specificity of CFTRinh-172 as a CFTR inhibitor, its rapid action, and its implications for cystic fibrosis research and secretory diarrhea models. This article provides a critical, mechanistic perspective and practical assay guidance that extends beyond standard protocols.

475 records 10/32 page Previous Next First page 上5页 678910 下5页 Last page